These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33351619)

  • 21. Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1.
    Wu J; Luo Y; Jiang Q; Li S; Huang W; Xiang L; Liu D; Hu Y; Wang P; Lu X; Zhang G; Wang F; Meng X
    Pharmacol Res; 2019 Sep; 147():104348. PubMed ID: 31336157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol inhibits NLRP3 inflammasome in fibroblast-like synoviocytes activated by lipopolysaccharide and adenosine triphosphate.
    Shi J; Zhao W; Ying H; Zhang Y; Du J; Chen S; Li J; Shen B
    Int J Rheum Dis; 2018 Nov; 21(11):2002-2010. PubMed ID: 29105345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation.
    Qiu Q; Yang Z; Cao F; Yang C; Hardy P; Yan X; Yang S; Xiong W
    Exp Cell Res; 2020 Jan; 386(2):111737. PubMed ID: 31759058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laurus nobilis leaf extract controls inflammation by suppressing NLRP3 inflammasome activation.
    Lee EH; Shin JH; Kim SS; Lee H; Yang SR; Seo SR
    J Cell Physiol; 2019 May; 234(5):6854-6864. PubMed ID: 30387132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRP3 Inflammasome in Acute Myocardial Infarction.
    Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome.
    Chiu HW; Li LH; Hsieh CY; Rao YK; Chen FH; Chen A; Ka SM; Hua KF
    Sci Rep; 2019 Apr; 9(1):5603. PubMed ID: 30944389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivo.
    Chen Y; Li R; Wang Z; Hou X; Wang C; Ai Y; Shi W; Zhan X; Wang JB; Xiao X; Bai Z; Sun H; Xu G
    Cell Immunol; 2020 Mar; 349():104046. PubMed ID: 32057354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway.
    Chen H; Ding Y; Chen W; Feng Y; Shi G
    Drug Des Devel Ther; 2019; 13():1545-1554. PubMed ID: 31123394
    [No Abstract]   [Full Text] [Related]  

  • 31. Intermedin
    Wu D; Shi L; Li P; Ni X; Zhang J; Zhu Q; Qi Y; Wang B
    Inflammation; 2018 Mar; 41(2):505-514. PubMed ID: 29192367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Inhibition of NLRP3 Inflammasome and IL-6 Production by
    Tomani JCD; Kagisha V; Tchinda AT; Jansen O; Ledoux A; Vanhamme L; Frederich M; Muganga R; Souopgui J
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
    Hu Q; Zhang T; Yi L; Zhou X; Mi M
    Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
    Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
    Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice.
    Zhao J; Wang Z; Yuan Z; Lv S; Su Q
    Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs as important regulators of the NLRP3 inflammasome.
    Zamani P; Oskuee RK; Atkin SL; Navashenaq JG; Sahebkar A
    Prog Biophys Mol Biol; 2020 Jan; 150():50-61. PubMed ID: 31100298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPAR-
    Meng QQ; Feng ZC; Zhang XL; Hu LQ; Wang M; Zhang HF; Li SM
    Mediators Inflamm; 2019; 2019():6386729. PubMed ID: 31015796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.